Top insights from the latest market news from Tuesday, April 21, from The Motley Fool analysts on Team Rule Breakers and Team ...
This property and casualty insurer for U.S. homeowners reported a notable insider sale amid a year of modest stock declines.
PVH Insider Sells $642K in Stock Amid 40% Rally and Strong 2025 Results. What Should Investors Know?
Backed by brands like Tommy Hilfiger and Calvin Klein, this global apparel leader reported a notable insider sale in recent ...
Why are the major indexes down on a quiet news day? Apple's leadership shakeup is doing most of the heavy lifting.
A growing number of tech companies are making their own chips in an effort to be less dependent on Nvidia. Nvidia's stock ...
Glacier Bancorp. We successfully closed two strategic acquisitions: Bank of Idaho in April and Guaranty Bank & Trust in ...
I will now provide detailed updates, starting with our second quarter FY 2026 performance. Our learning services achieved ...
This afternoon, Cathay General Bancorp issued an earnings release outlining its fourth quarter and full year 2025 results. To ...
President Trump also made comments today, suggesting he is not supportive of a merger between United and American. Oil prices ...
However, you have to put the drawdown into a larger context. The stock is still up more than 35% over the past year. If you ...
Tuesday, April 21, 2026 at 2 p.m. ET. CALL PARTICIPANTS. President & CEO — Johnny Lee; EVP & CFO — Lynn Hopkins; Need a quote from a Motley Fool analyst? Email [email pr ...
Viridian Therapeutics is a clinical-stage biotech awaiting an FDA decision on its lead thyroid eye disease therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results